Hiroki Ogo

Analysis of effects and pharmacokinetics of subcutaneously administered BDNF

Akiyoshi Kishino, Noriko Katayama, Yohko Ishige et al. · Neuroreport · 2001 · 73 citations

Peripheral Nerve Injury, Pharmacotherapy, Peripheral Nerve +16

Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study

Makoto Uchiyama, Daiji Kambe, Yumiko Imadera et al. · Psychopharmacology · 2022 · 24 citations · Full text

Human Astrocytoma Cells (U‐87 MG) Exhibit a Specific Substance P Binding Site with the Characteristics of an NK‐1 Receptor

Hiroki Ogo, Naoyoshi Kuroyanagi, Atsuko Inoue et al. · Journal of Neurochemistry · 1996 · 19 citations

Pharmacokinetics, pharmacodynamics and safety profile of the dual orexin receptor antagonist vornorexant/TS‐142 in healthy Japanese participants following single/multiple dosing: Randomized, double‐blind, placebo‐controlled phase‐1 studies

Daiji Kambe, Sayaka Hasegawa, Yumiko Imadera et al. · Basic & Clinical Pharmacology & Toxicology · 2023 · 14 citations · Full text

Methionine-free brain-derived neurotrophic factor in wobbler mouse motor neuron disease: dose-related effects and comparison with the methionyl form

Takeo Ishiyama, Hiroki Ogo, Vivian Wong et al. · Brain Research · 2002 · 11 citations

Neurodegenerative Diseases, Physiology, Methionyl Form +8